WenJiangMD

PubMed

• 20 citations
  Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-...
  Xiaotao Huang, Qiaodan Liu, Guihua Zhong, Yingpeng Peng, Ye Liu
  Journal of Experimental & Clinical Cancer Research. 2022-10-12
• 255 citations
  Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions.
  Yifan Wang, Weiye Deng, Nan Li, Shinya Neri, Amrish Sharma
  Frontiers in Pharmacology. 2018-03-05
• 6 citations
  Author Correction: Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
  Zhaogang Yang, Junfeng Shi, Jing Xie, Yifan Wang, Jingyao Sun
  Nature Biomedical Engineering. 2021-06-15

Journal Articles

• Therapeutic remodeling of the tumor microenvironment enhances nanoparticle delivery  
  Chen Y, Liu X, Yuan H, von Roemeling CA, Qie Y, Knight JA, Wang Y, Yun K, Jiang W, Kim BYS, Adv. Science, 1/1/2019
• Multi-institutional Investigation: Circulating CD4: CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides  
  An Y, Jiang W (co-first), Andraos TY, Reddy JP, Yehia ZA, Lloyd S, Duvic M, D'Souza NM, Milgrom SA, Pinnix CC, Oki Y, Smith GL, Wilson LD, Dabaja BS, Radiother Oncol, 1/1/2019
• The Reciprocity Between Radiotherapy and Cancer Immunotherapy  
  Wen Jiang, Jing Li, Clinical Cancer Research
• The reciprocity cancer immunotherapy and radiotherapy  
  Wang Y, Liu ZG, Huang YH, Li J, Kim BYS, Story MD, Jiang W, Clinical Cancer Research, 1/1/2018
• Pre-treatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio are Prognostic of Progression in Early Stage Classical Hodgkin Lymphoma  
  Reddy JP, Hernandez M, Gunther JR, Dabaja BS, Martin GV, Jiang W, Akhtari M, Allen PK, Atkinson BJ, Smith GL, Pinnix CC, Milgrom SA, Yehia ZA, Osborne EM, Oki Y, Lee H..., Br J Haematology, 1/1/2018
• High Lymphocyte Count during Neoadjuvant Chemoradiotherapy is Associated with Improved Pathologic Complete Response in Esophageal Cancer  
  Fang P, Jiang W, Rajayogesh D, Xu C, Krishnan SK, Mohan R, Koong AC, Hsu CC, Lin SH, Radiotherapy and Oncology, 1/1/2018
• Lymphocyte-Sparing Effect of Proton Therapy in Esophageal Cancer Patients Treated with Definitive Chemoradiation  
  Fang P, Shiraishi Y, Jiang W, Song J, Hobbs BP, Lin SH, Int J Particle Ther, 1/1/2018
• Combination of Immunotherapy and Radiotherapy for Cancer Treatment: Current Progress and Future Directions  
  Wang Y, Deng W, Li N, Neri S, Sharma A, Jiang W, Lin SH, Front Pharmacol, 1/1/2018
• Efficacy and Toxic Effects of Cancer Immunotherapy Combinations: A Double-Edged Sword  
  Tang C, Jiang W, Yap TA, JAMA Oncology, 1/1/2018
• Tumor vasculature: A new target for cancer immunotherapy  
  Liu Z, Yuan H, Wang Y, Yan Z, Huang YH, Kim BYS, Jiang W, Trends Pharm. Sci. (Cell Press), 1/1/2018
• Immune modulating nanomedicine for cancer therapy  
  Liu Z, Jiang W, Nam J, Moon JJ, Kim, BYS, Nano Letters, 1/1/2018
• Mutant LKB1 confers enhanced radiosensitization in combination with trametinib in KRAS-mutant non-small cell lung cancer  
  Wang Y, Li N, Jiang W, Deng W, Ye R, Xu C, Qiao Y, Sharma A, Zhang M, Hung MC, Lin SH, Clinical Cancer Research, 1/1/2018
• Increased vessel perfusion predicts the therapeutic efficacy of immune checkpoint blockade  
  Zheng X, Fang Z, Wang X, Zhang C, Yin R, Wen C, Liu X, Deng S, Zhou P, Hu H, Chen X, Wang X, Zhao Y, Xin L, Lin *SH, Kim BYS, Jiang W, Wu Q, Huang YH, Journal of Clinical Investigation, 1/1/2018
• Improving immune-vascular crosstalk for cancer immunotherapy  
  Huang YH, Kim BYS, Chan CK, Hahn SM, Weissman IL, Jiang W, Nature Rev Immunology, 1/1/2018
• Estimating Survival in Melanoma Patients with Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)  
  Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Amatruda T, Sperduto WA, Kirkpatrick JP..., Int J Rad Onc Biol Phys, 1/1/2017
• S100A4 is a biomarker and regulator of glioma stem cells that is critical for mesenchymal transition in glioblastoma  
  Chow KH, Park HJ, George J, Yamamoto K, Gallup AD, Graber J, Chen YX, Jiang W, Steindler D, Neilson EG, Kim BYS, Yun K, Cancer Research, 1/1/2017
• Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control  
  An Y, Jiang W, Kim BYS, Qian J, Tang C, Fang P, D'Souza NM, Haydu L, Mahajan A, Lin SH, Davies MA, Hwu P, Sulman EP, Brown PD, Chang V, Li J, Radiotherapy and Oncology, 1/1/2017
• A Predictive Model for Distinguishing Radiation Necrosis from Tumor Progression after Gamma Knife Radiosurgery based on Radiomics Features from Magnetic Resonance Images  
  Zhang Z, Yang J, Ho A, Jiang W, Wang XA, Brown PD, Guha-Thakurta N, Ferguson SD, Fave X, Zhang L, Mackin D, Court LE, Jing Li, Eur Radiology, 1/1/2017
• The Prognostic Value of BRAF, cKIT, and NRAS Mutations in Melanoma Patients with Brain Metastases  
  Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson D, Shih HA, Bangdiwala A, Shanley R, Lockney N, Beal K, Lou E, Amatruda T, Sperduto W, Kirkpatrick JP, Y..., Int J Rad Onc Biol Phys, 1/1/2017
• Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma  
  Fang P, Jiang W, Allen P, Glitza I, Guha N, Hwu P, Ghia A, Phan J, Mahajan A, Tawbi H, Li J, J. Neuro-Oncol, 1/1/2017
• Lymphocyte Nadir and Esophageal Cancer Survival Outcomes Following Chemoradiotherapy  
  Davuluri R, Jiang W, Fang P, Xu C, Komaki R, Gomez DR, Welsh JW, Cox JD, Crane CH, Hsu CC, Lin SH, Int J Rad Onc Biol Phys, 1/1/2017
• Breaking Down the Barriers to Precision Cancer Nanomedicine  
  von Roemling C, Jiang W, Chan CK, Weissman IL, Kim BYS, Trends in Biotechnol (Cell Press), 1/1/2017
• Multivalent Bi-Specific Nano-Bioconjugate Engager for Targeted Cancer Immunotherapy  
  Yuan H, Jiang W, von Roemeling CA, Qie Y, Liu X, Chen Y, Wharen RE, Yun K, Bu G, Knutson KL, Kim BYS, Nature Nanotechnology, 1/1/2017
• Designing next generation cancer nanomedicine for immuno-oncology  
  Jiang W, von Roemeling C, Qie Y, Chen Y, Liu X, Chen J, Kim BYS, Nature Biomed Eng, 1/1/2017
• RAD50 expression is associated with poor clinical outcomes after radiotherapy in resected non-small cell lung cancer  
  Wang Y, Gudikote J, Yan J, Deng W, Jiang W, Li N, Ye R, Hobbs BP, Wang J, Swisher SG, Fujimoto J, Wistuba II, Komaki R, Heymach JV, Lin SH, Clin Cancer Res, 1/1/2017
• Join now to see all

Books/Book Chapters

• Contemporary Management of Intracranial Gliomas 
  Chapter: Perspectives of nanotechnology in the management of gliomas. 
  Yoon JW, Jiang W, Rutka JTR, Huang Y, Kim BYSEditors: Chernov MF, Muragaki Y, Kesari S, McCutcheon IE.Karger Medical and Scientific Publishers, BerlinEdition 1st,2015
• Therapeutic Micro/Nanotechnology 
  Chapter: Engineering biocompatible quantum dots for real-time, ultrasensitive biological imaging and detection. 
  Page 137 - 156Jiang W, Singhal A, Fischer H, Mardyani S, Chan WCWEditors: Bhatia S, and Desai T.Kluwer Publishing2006
• Biological Nanostructures and Applications of Nanostructures in Biology 
  Chapter: Bioinspired approaches to build nanoscale devices. 
  Page 149 - 161Mardyani S, Jiang W, Lai J, Zhang J, Chan, WCWEditors: Stoscio M, and Dutta M.Kluwer Publishing2004

Abstracts/Posters

• Multiplex in situ immunoprofiling and survival outcomes in non-small cell lung cancer.
  Lin SH, Mansfield JR, Rao X, Jiang W, Fang P, Roman K, Wang C, Komaki R, Hahn S, Swisher SG, Fujimoto J, Wistuba I, Wang J, Hoyt CC, AACR (American Association for Cancer Research) Annual Meeting, New Orleans, LA, 1/1/2016
• Circulating myeloid precursor profile as potential marker to differentiate radiation changes from tumor recurrence after brain stereotactic radiosurgery.
  Jiang W, AACR (American Association for Cancer Research) Annual Meeting, Philadelphia, PA, 1/1/2015

Lectures

• Selective macrophage evading nanomedicine enables enhanced delivery and therapeutic efficacy of anti-cancer agents against solid tumors. 
  Mount Snow, VT - 1/1/2017
• CD4:CD8 Ratio in Mycosis Fungoides: Prognostic and Predictive Value of Circulating T lymphocyte Subsets for Outcomes after Total Skin Electron Beam Radiation. 
  Boston, MA - 1/1/2016
• Circulating Lymphocyte Count During Neoadjuvant Chemoradiation Therapy for Esophageal Cancer as a Predictive Biomarker of Pathologic Complete Response. 
  Boston, MA - 1/1/2016
• Temporally-Dependent Intracranial Control of Melanoma Brain Metastasis by Stereotactic Radiation Therapy in Patients Treated With Immune Checkpoint Blockade. 
  San Antonio, TX - 1/1/2015
• Microenvironmental modulation improves nanomedicine delivery into brain tumors. 
  San Antonio, TX - 1/1/2015
• Temporally dependent intracranial control of melanoma brain metastasis by stereotactic radiotherapy in patients treated with immune-checkpoint blockade. 
  Hunan, China - 1/1/2015
• Idh1 Status As a Complementary Marker Formalignant Astrocytomas with Limited Surgical Specimen. 
  Seoul, Korea - 1/1/2013
• Vascular normalization enhances the delivery of nanoparticle carriers into solid tumors. 
  Stanford, CA - 1/1/2010
• Live cell labeling and imaging with intracellularly delivered quantum dot probes. 
  Boston, MA - 1/1/2009
• Nanotechnology and brain tumors. 
  Vancouver, British Columbia, Canada - 1/1/2009
• Biodegradable quantum dot nanocomposites for intracellular delivery and imaging of live cells. 
  San Francisco, CA - 1/1/2008
• Nanoparticle-mediated cellular response is size dependent. 
  Toronto, Ontario, Canada - 1/1/2008
• Engineered nanoparticles for enhanced therapeutic and cellular responses 
  Vancouver, British Columbia, Canada - 1/1/2008
• Controlling cell fate using nanoparticle geometry. 
  Orlando, FL - 1/1/2008
• Size-control of nanoparticle intracellular delivery and its effects. 
  Toronto, Ontario, Canada - 1/1/2008
• Optimizing near-IR CdTexSe1-x alloyed quantum dots for biomedical imaging. 
  Chicago, IL - 1/1/2006
• Novel quantum dot-antibody probes for in vivo fluorescence endoscopic detection of precancerous lesions of the gastrointestinal tract. 
  Toronto, Ontario, Canada - 1/1/2006
• Near-infrared emitting quantum dots for enhanced bioimaging. 
  Montreal, Quebec, Canada - 1/1/2005
• Nanocrystal contrast agents for enhanced biological imaging. 
  Toronto, Ontario, Canada - 1/1/2005
• Multiplexed quantum dot fluorescence imaging by In Vivo targeting of epidermal growth factor receptor (EGFR) and villin expression in Barrett's esophagus (BE) surgical... 
  Washington, DC - 1/1/2005
• Surface plasmon coupled emission of quantum dots. 
  San Diego, CA - 1/1/2004
• Surface modification of semiconductor quantum dots for biological imaging. 
  Toronto, Ontario, Canada - 1/1/2004
• Ultrasensitive molecular imaging using quantum dots-bioconjugates. 
  Indianapolis, IN - 1/1/2004
• Biological applications of semiconductor quantum dots. 
  Toronto, Ontario, Canada - 1/1/2004
• Join now to see all